about
Antimicrobial peptides and the skin immune defense systemThe use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic reviewInterferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarialsPRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRPContext mediates antimicrobial efficacy of kinocidin congener peptide RP-1Vertebrate TFPI-2 C-terminal peptides exert therapeutic applications against Gram-negative infectionsPlatelet Rich Fibrin in Periodontal RegenerationThymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILKAntimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes.Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins.Identification and characterization of thymosin beta-4 in chicken macrophages using whole cell MALDI-TOF.Platelets as an innate defence mechanism against Schistosoma mansoni infections in mice.Human platelets attenuate Aspergillus species via granule-dependent mechanisms.SufA - a bacterial enzyme that cleaves fibrinogen and blocks fibrin network formation.Human platelets efficiently kill IgG-opsonized E. coliBidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections?Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion.Association of thrombocytopenia with outcome following adult living donor liver transplantation.Platelets in defense against bacterial pathogens.Antimicrobial peptides: primeval molecules or future drugs?Treatment of life-threatening wounds with a combination of allogenic platelet-rich plasma, fibrin glue and collagen matrix, and a literature reviewMultidimensional signatures in antimicrobial peptidesCandidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation.Platelets promote mitochondrial uncoupling and resistance to apoptosis in leukemia cells: a novel paradigm for the bone marrow microenvironmentDltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.Transposon disruption of the complex I NADH oxidoreductase gene (snoD) in Staphylococcus aureus is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1.Severe malarial anemia: innate immunity and pathogenesis.Platelet-rich plasma and adipose-derived mesenchymal stem cells for regenerative medicine-associated treatments in bottlenose dolphins (Tursiops truncatus).Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape.Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum.Thrombopoietin contributes to neuronal damage in experimental bacterial meningitis.Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activityTemporal Bacteriostatic Effect and Growth Factor Loss in Equine Platelet Components and Plasma Cultured with Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus: A Comparative In Vitro StudyThe role of platelet gel in osteoarticular injuries of young and old patients.Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 in vitro associated with qacA gene carriage is independent of multidrug efflux pump activityA peptide inhibitor of cytomegalovirus infection from human hemofiltrate
P2860
Q24654981-08B02660-3985-47DD-BB28-2423FD995157Q26747075-B37BCE99-064D-4E70-B721-D24994B15369Q27312575-847FFB68-539A-47F6-A0C9-4653568B9B44Q28281539-92E1E308-2E74-4E1A-B7B5-C1784DE75B9AQ28382940-95A82BE6-564C-42B4-9F92-E932B0ECC7C5Q28477816-03412D9C-B96A-4CCC-8597-1153196F68E4Q28597180-610D25E7-7E69-433A-B617-18E23E4DA83FQ28829938-24978C08-87DB-4B16-8197-9BD5F18FB39FQ28910436-55FC5089-AF8E-4288-B3FD-9CC367194591Q30438323-18210112-2876-4572-8F09-F2981BA1649FQ33206053-E06A345D-4245-454E-82EC-D78C232E0770Q33268976-A8293144-708D-422F-9112-E89A18C8B082Q33303160-EE31815A-1D6D-4E69-84D5-3420ACB03331Q33360916-84D3C717-F18B-4732-AEBD-404FB1F77FF4Q33364233-716A725C-01D2-41BC-B394-FE7CD67894D3Q33396819-5A1AEF85-BCE3-46D5-91BE-C2E5D06764B2Q33399755-3DB00FC1-5C1D-4344-8221-C3FE89ED7ACFQ33401507-2742D307-EA42-43EC-B9B2-45DA0E27B2E5Q33406904-8D7E6F4B-8C98-4726-9E0F-DA41E569393AQ33410913-BBDAB372-117E-4481-AA29-020EA1DFBF2EQ33433980-E8FBE257-26A7-4DC4-B092-135F3BE69AEAQ33604443-6D5E07BF-4C46-4BA7-B19E-15C001316D67Q33742102-3A0F8FDE-4F6D-42FB-A117-94362A49A28AQ33837478-9A5AF3AD-413B-4112-A7ED-F4B45DB010EFQ33905204-C22F877D-9CCD-45DF-B999-47AC04CE24C8Q33927464-5EAA77C2-6F79-4FD5-809F-6B76911957B8Q34079154-5F3C0D30-8ED8-4A7A-8E47-7FDCD827A5B4Q34115953-453A1E5A-5FD9-429B-83E3-7BB181C9ECCEQ34194581-1B7D0FC6-9142-441E-97BA-D0DC2697A56EQ34233206-16F1231A-5615-4B89-BCB4-E7B81D86780FQ34235396-02B9C759-2C14-47CA-A0E5-5D51FD225550Q34254043-B321CD3B-5EF1-4BDE-A888-D6C92EAD2796Q34298556-1C45041E-8F59-471E-8850-38647ECF6382Q34316582-9AB59599-7533-4D93-85DB-88084C094D6FQ34529409-DC839D8C-F96A-4692-8B74-78C3318A04F7Q34541158-E6A57432-CA54-439F-AA8F-1195E79FFFE8Q34660494-4A136BE6-751F-4F7A-B0E2-89F186BEFEBAQ34678133-F05E32D3-8547-443D-B062-40F74B3755BAQ34721784-496FE388-14BA-465B-BA7E-3B92CB57DEE1Q34821852-8C09C89C-3EAF-4734-BBF8-AEED135F369D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Antimicrobial peptides from human platelets
@ast
Antimicrobial peptides from human platelets
@en
Antimicrobial peptides from human platelets
@nl
type
label
Antimicrobial peptides from human platelets
@ast
Antimicrobial peptides from human platelets
@en
Antimicrobial peptides from human platelets
@nl
prefLabel
Antimicrobial peptides from human platelets
@ast
Antimicrobial peptides from human platelets
@en
Antimicrobial peptides from human platelets
@nl
P2093
P2860
P1476
Antimicrobial peptides from human platelets
@en
P2093
Michael E Selsted
Michael R Yeaman
Yi-Quan Tang
P2860
P304
P356
10.1128/IAI.70.12.6524-6533.2002
P407
P577
2002-12-01T00:00:00Z